CARTITUDE-1 final results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma Meeting Abstract


Authors: Jagannath, S.; Martin, T.; Usmani, S.; Berdeja, J.; Jakubowiak, A.; Agha, M.; Cohen, A.; Deol, A.; Htut, M.; Lesokhin, A.; Munshi, N.; O'Donnell, E.; Jackson, C.; Yeh, T. M.; Banerjee, A.; Zudaire, E.; Madduri, D.; DelCorral, C.; Pacaud, L.; Lin, Y.
Abstract Title: CARTITUDE-1 final results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma
Meeting Title: 20th Annual Meeting and Exposition of the International Myeloma Society
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 23
Issue: Suppl. 2
Meeting Dates: 2023 Sep 27-30
Meeting Location: Athens, Greece
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2023-09-01
Start Page: S187
Language: English
ACCESSION: WOS:001079705400327
PROVIDER: wos
DOI: 10.1016/S2152-2650(23)01893-1
Notes: Meeting Abstract: P-275 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Meyer Lesokhin
    361 Lesokhin
  2. Saad Zafar Usmani
    288 Usmani